Norton Hospitals INC

Norton Hospitals INC was paid $419.58M by Medicaid between Jan 2018 and Nov 2022, across 892 billing codes. Its largest line is 99284, emergency room visit (serious) — 13% of everything it billed.

33Billing provider infoNORTON HOSPITALS INC
LOUISVILLE, KY 40202

33aNPI1043348808assigned 03/01/2007

33bProvider typePsychiatric Hospital Unit

28Total paid$419.58M

24GClaims5,948,130

24DCodes billed892

24AFirst – last monthJan 2018 – Nov 2022

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official GAST, SHELLEY controls 20+ related entities in our dataset. Read more

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	1,259,556	$71.11M
2019	1,244,257	$75.93M
2020	1,141,455	$74.04M
2021	1,278,407	$106.80M
2022	1,024,455	$91.70M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99284	Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity	13%	172,180	145,714	$53.75M
99283	Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity	9.6%	181,711	162,844	$40.47M
99285	Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life	4.5%	64,361	45,968	$19.07M
74177	Computed tomography, abdomen and pelvis; with contrast material	2.9%	31,946	28,254	$11.98M
99282	Emergency department visit for the evaluation and management, low to moderate severity	2.8%	57,392	52,311	$11.55M
93306	Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete	2.2%	19,342	16,684	$9.35M
G0378	Hospital observation service, per hour	2.0%	52,668	23,231	$8.21M
C1776	Joint device (implantable)	1.8%	782	683	$7.51M
J9271	Injection, pembrolizumab, 1 mg	1.7%	1,347	808	$7.31M
C1713	Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable)	1.7%	5,303	4,322	$7.18M
70450	Computed tomography, head or brain; without contrast material	1.7%	35,783	30,019	$7.11M
70551	Magnetic resonance imaging, brain; without contrast material	1.4%	11,598	10,516	$5.87M

880 more codes

72148	Magnetic resonance imaging, lumbar spine; without contrast material	1.4%	10,752	$5.84M
70553	Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences	1.3%	10,518	$5.46M
96375	Therapeutic injection; each additional sequential IV push	1.1%	74,558	$4.62M
J1745	Injection, infliximab, excludes biosimilar, 10 mg	1.1%	1,592	$4.56M
78815	Positron emission tomography (PET) for limited area imaging	<1%	2,061	$3.86M
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	<1%	135,986	$3.58M
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	<1%	75,838	$3.54M
74176	Computed tomography, abdomen and pelvis; without contrast material	<1%	11,581	$3.45M
71275	Computed tomographic angiography, chest, with contrast material	<1%	10,934	$3.31M
77386		<1%	7,611	$3.29M
72141		<1%	5,800	$3.19M
96361	Intravenous infusion, hydration; each additional hour	<1%	93,860	$3.18M
87637	Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV	<1%	25,135	$3.03M
78452	Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress	<1%	9,681	$2.98M
43239	Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple	<1%	7,735	$2.82M
J0585	Injection, onabotulinumtoxina, 1 unit	<1%	6,172	$2.65M
71260	Computed tomography, thorax, diagnostic; with contrast material	<1%	8,810	$2.58M
96413	Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance	<1%	19,271	$2.51M
58661		<1%	1,182	$2.40M
J3490	Unclassified drugs	<1%	234,043	$2.39M
80053	Comprehensive metabolic panel	<1%	244,382	$2.37M
99281	Emergency department visit for the evaluation and management, self-limited or minor	<1%	14,392	$2.36M
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	<1%	99,987	$2.33M
62323		<1%	6,270	$2.29M
47562		<1%	1,361	$2.20M
73721	Magnetic resonance imaging, any joint of lower extremity; without contrast material	<1%	4,518	$2.20M
58571		<1%	873	$2.15M
93458		<1%	1,473	$2.02M
72125	Computed tomography, cervical spine; without contrast material	<1%	8,748	$2.02M
76770		<1%	11,851	$1.93M
71045	Radiologic examination, chest; single view	<1%	58,733	$1.79M
42820	Tonsillectomy and adenoidectomy; younger than age 12	<1%	1,235	$1.75M
93017		<1%	7,795	$1.74M
69436	Tympanostomy (requiring insertion of ventilating tube), general anesthesia	<1%	2,168	$1.71M
71250		<1%	7,816	$1.71M
44970		<1%	744	$1.71M
93320		<1%	7,092	$1.70M
71046	Radiologic examination, chest; 2 views	<1%	39,451	$1.65M
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	67,824	$1.58M
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	<1%	71,114	$1.57M
76705	Ultrasound, abdominal, real time with image documentation; limited	<1%	12,656	$1.48M
45380	Colonoscopy, flexible; with biopsy, single or multiple	<1%	3,131	$1.46M
J2323	Injection, natalizumab, 1 mg	<1%	338	$1.42M
96360	Intravenous infusion, hydration; initial, 31 minutes to 1 hour	<1%	30,682	$1.38M
J2350	Injection, ocrelizumab, 1 mg	<1%	78	$1.35M
95810	Polysomnography; sleep staging with 4 or more additional parameters	<1%	3,062	$1.34M
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	248,520	$1.30M
93303	Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study	<1%	6,243	$1.27M
77067	Screening mammography, bilateral, including computer-aided detection	<1%	15,893	$1.27M
76830	Ultrasound, transvaginal	<1%	9,940	$1.25M
36512		<1%	1,578	$1.20M
72131		<1%	4,351	$1.19M
72146		<1%	2,295	$1.16M
45378	Colonoscopy, flexible; diagnostic, including collection of specimen(s)	<1%	2,346	$1.14M
41899	Unlisted procedure, dentoalveolar structures	<1%	2,200	$1.13M
74019		<1%	17,156	$1.11M
36415	Collection of venous blood by venipuncture	<1%	286,765	$1.08M
87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	<1%	4,837	$1.07M
45385	Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s)	<1%	2,229	$1.06M
96376		<1%	18,657	$1.06M
97110	Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion	<1%	25,127	$1.06M
73221		<1%	2,237	$1.04M
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	<1%	21,395	$1.02M
G0463	Hospital outpatient clinic visit for assessment and management of a patient	<1%	23,047	$988K
70496		<1%	2,906	$953K
76856	Ultrasound, pelvic (nonobstetric), real time with image documentation; complete	<1%	7,996	$925K
J3380	Injection, vedolizumab, intravenous, 1 mg	<1%	185	$914K
J2505	Injection, pegfilgrastim, 6 mg	<1%	282	$908K
77334		<1%	1,979	$895K
99291	Critical care, evaluation and management of the critically ill patient, first 30-74 minutes	<1%	1,763	$858K
70491		<1%	3,166	$849K
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	12,466	$843K
70486		<1%	3,713	$825K
J0185	Injection, aprepitant, 1 mg	<1%	3,892	$815K
93975		<1%	6,370	$808K
62321		<1%	2,023	$803K
70498		<1%	2,833	$800K
74018		<1%	13,334	$800K
76536		<1%	6,391	$797K
93971		<1%	7,314	$790K
83880		<1%	39,430	$785K
72158		<1%	1,640	$781K
64615		<1%	6,479	$775K
76642		<1%	8,720	$770K
36561		<1%	874	$753K
P9016	Red blood cells, leukocytes reduced, each unit	<1%	4,628	$744K
11042	Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm	<1%	5,709	$728K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	25,240	$722K
97530	Therapeutic activities, direct patient contact, each 15 minutes	<1%	17,590	$707K
J9312	Injection, rituximab, 10 mg	<1%	193	$705K
74178		<1%	1,445	$704K
77412		<1%	3,548	$704K
C1769	Guide wire	<1%	8,049	$684K
64721		<1%	970	$663K
54161		<1%	1,219	$655K
20680		<1%	695	$629K
96367		<1%	11,764	$624K
95713		<1%	2,282	$609K
74183		<1%	1,233	$606K
70544		<1%	1,704	$590K
Q5118	Injection, bevacizumab-bvzr, biosimilar, (zirabev), 10 mg	<1%	329	$586K
93325		<1%	8,727	$583K
96415		<1%	4,387	$580K
93970		<1%	4,050	$575K
96366	Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour	<1%	12,189	$574K
72156		<1%	1,123	$571K
77063	Screening digital breast tomosynthesis, bilateral	<1%	14,784	$570K
76700	Ultrasound, abdominal, real time with image documentation; complete	<1%	3,258	$562K
C1725	Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability)	<1%	2,375	$555K
99211	Office or other outpatient visit for the evaluation and management of an established patient, minimal severity	<1%	29,525	$547K
95811		<1%	1,281	$545K
84484		<1%	70,752	$541K
72197		<1%	1,017	$534K
54300		<1%	512	$532K
J0897	Injection, denosumab, 1 mg	<1%	544	$512K
73630		<1%	11,289	$512K
76817	Ultrasound, pregnant uterus, real time with image documentation, transvaginal	<1%	6,555	$505K
96417		<1%	4,617	$505K
59025	Fetal non-stress test	<1%	13,190	$497K
76801		<1%	6,915	$493K
77066	Tomosynthesis, mammo	<1%	4,420	$484K
C1781	Mesh (implantable)	<1%	914	$480K
Q5111	Injection, pegfilgrastim-cbqv (udenyca), biosimilar, 0.5 mg	<1%	215	$436K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	13,739	$434K
78227		<1%	1,213	$432K
67311		<1%	391	$429K
A9552	Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries	<1%	3,818	$424K
19083		<1%	831	$422K
58558		<1%	486	$413K
95782		<1%	697	$412K
77300		<1%	1,595	$411K
92507	Treatment of speech, language, voice, communication, and/or auditory processing disorder	<1%	9,330	$406K
J2469	Injection, palonosetron hcl, 25 mcg	<1%	4,861	$402K
77336		<1%	4,481	$400K
36430		<1%	3,310	$397K
J9306	Injection, pertuzumab, 1 mg	<1%	82	$391K
78264		<1%	1,688	$370K
76870		<1%	3,241	$367K
43235		<1%	1,151	$362K
51600		<1%	2,737	$362K
99213	Doctor's office visit, returning patient (routine)	<1%	17,044	$361K
73610		<1%	9,684	$358K
93225		<1%	3,899	$355K
73562		<1%	9,067	$352K
36593		<1%	2,188	$347K
52332		<1%	667	$341K
74455		<1%	3,050	$340K
A9575	Injection, gadoterate meglumine, 0.1 ml	<1%	15,065	$338K
J1756	Injection, iron sucrose, 1 mg	<1%	6,000	$334K
C1874	Stent, coated/covered, with delivery system	<1%	151	$333K
73030		<1%	8,036	$332K
72157		<1%	611	$328K
64642		<1%	1,046	$327K
77290		<1%	2,387	$324K
J9299	Injection, nivolumab, 1 mg	<1%	88	$321K
64643		<1%	902	$321K
77065	Tomosynthesis, mammo	<1%	4,397	$318K
J2785	Injection, regadenoson, 0.1 mg	<1%	4,685	$318K
64493		<1%	649	$315K
73130		<1%	8,889	$310K
97112	Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination	<1%	7,378	$309K
80048	Basic metabolic panel (calcium, ionized)	<1%	44,052	$307K
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	23,467	$307K
J9310	Injection, rituximab, 100 mg	<1%	94	$303K
Q0138	Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)	<1%	741	$301K
93798		<1%	9,740	$301K
C1762	Connective tissue, human (includes fascia lata)	<1%	85	$297K
78492		<1%	288	$296K
95951		<1%	1,611	$295K
95812		<1%	1,127	$294K
A9500	Technetium tc-99m sestamibi, diagnostic, per study dose	<1%	5,189	$291K
93351		<1%	733	$290K
77295		<1%	293	$290K
C1894	Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser	<1%	4,541	$286K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	17,230	$284K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	17,442	$284K
95816		<1%	1,832	$284K
72128		<1%	1,309	$281K
G0382	Level 3 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment)	<1%	1,704	$281K
72132		<1%	1,350	$277K
84443	Thyroid stimulating hormone (TSH)	<1%	19,097	$273K
86920		<1%	4,936	$268K
G0260	Injection procedure for sacroiliac joint; provision of anesthetic, steroid and/or other therapeutic agent, with or without arthrography	<1%	938	$267K
51728		<1%	1,419	$265K
95700		<1%	2,237	$259K
J1459	Injection, immune globulin (privigen), intravenous, non-lyophilized (e.g., liquid), 500 mg	<1%	224	$258K
88341		<1%	2,451	$256K
72110		<1%	5,108	$255K
C1887	Catheter, guiding (may include infusion/perfusion capability)	<1%	2,614	$254K
95716		<1%	850	$251K
95886		<1%	1,770	$247K
93922		<1%	2,389	$246K
95813		<1%	1,189	$245K
78431		<1%	212	$243K
C1788	Port, indwelling (implantable)	<1%	679	$242K
83735		<1%	46,813	$239K
88342		<1%	6,005	$239K
G0121	Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk	<1%	549	$235K
74230		<1%	2,164	$232K
J1439	Injection, ferric carboxymaltose, 1 mg	<1%	418	$232K
96411		<1%	2,715	$231K
77080		<1%	4,000	$229K
95819		<1%	1,397	$227K
73090		<1%	6,436	$226K
50590		<1%	116	$226K
86850		<1%	30,007	$224K
78306		<1%	1,159	$224K
73590		<1%	6,133	$219K
73110		<1%	6,283	$216K
72100		<1%	4,588	$216K
J9022	Injection, atezolizumab, 10 mg	<1%	53	$216K
97161		<1%	7,614	$215K
93880		<1%	2,030	$213K
M0243	Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring	<1%	1,348	$208K
76885		<1%	1,710	$205K
G0297	Low dose ct scan (ldct) for lung cancer screening	<1%	1,493	$205K
88185		<1%	839	$202K
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	15,723	$200K
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	<1%	7,919	$200K
82728		<1%	15,539	$198K
C2617	Stent, non-coronary, temporary, without delivery system	<1%	1,413	$196K
84703		<1%	47,640	$194K
81025		<1%	44,551	$193K
54163		<1%	239	$193K
87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	<1%	12,341	$191K
83690		<1%	51,759	$189K
J2704	Injection, propofol, 10 mg	<1%	65,379	$188K
88307		<1%	2,312	$188K
22551		<1%	51	$187K
12011		<1%	3,738	$186K
72040		<1%	3,871	$183K
76882		<1%	1,942	$182K
J2997	Injection, alteplase recombinant, 1 mg	<1%	4,075	$180K
77062		<1%	4,024	$178K
81229		<1%	241	$178K
86900		<1%	33,444	$177K
29881		<1%	131	$175K
10060		<1%	2,731	$169K
C1760	Closure device, vascular (implantable/insertable)	<1%	962	$168K
94060		<1%	1,674	$165K
74240		<1%	1,484	$164K
27447		<1%	201	$161K
97162		<1%	4,737	$160K
Q5103	Injection, infliximab-dyyb, biosimilar, (inflectra), 10 mg	<1%	85	$158K
80061	Lipid panel	<1%	12,380	$158K
A4648	Tissue marker, implantable, any type, each	<1%	1,678	$156K
76819	Fetal biophysical profile; without non-stress testing	<1%	2,197	$156K
75574		<1%	402	$155K
12001		<1%	3,252	$154K
76825		<1%	873	$153K
77072		<1%	2,476	$152K
94726		<1%	1,932	$151K
86902		<1%	3,155	$148K
87086	Culture, bacterial; quantitative colony count, urine	<1%	38,012	$147K
93226		<1%	3,517	$147K
73560		<1%	3,794	$146K
97535	Self-care/home management training, each 15 minutes	<1%	8,530	$144K
73700		<1%	681	$144K
J9202	Goserelin acetate implant, per 3.6 mg	<1%	320	$143K
73070		<1%	4,619	$142K
74174		<1%	319	$142K
85730		<1%	37,971	$142K
92611		<1%	1,857	$140K
29580		<1%	3,797	$138K
81001		<1%	82,416	$136K
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	<1%	8,134	$136K
49083		<1%	555	$135K
A9555	Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries	<1%	821	$135K
76800		<1%	926	$134K
77061		<1%	3,550	$134K
82565		<1%	11,257	$134K
51784		<1%	1,464	$133K
Q9969	Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study dose	<1%	8,698	$132K
77002		<1%	1,700	$131K
99157		<1%	2,467	$130K
73502		<1%	3,601	$130K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	5,248	$130K
73521		<1%	2,181	$128K
94010		<1%	3,033	$125K
54640		<1%	96	$125K
Q5107	Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg	<1%	97	$124K
85027		<1%	31,670	$124K
97140	Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage)	<1%	4,914	$123K
85610		<1%	46,352	$123K
97116		<1%	6,219	$123K
U0004	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r	<1%	3,071	$122K
95910		<1%	847	$121K
C1726	Catheter, balloon dilatation, non-vascular	<1%	783	$121K
20936		<1%	317	$121K
20930		<1%	234	$121K
62304		<1%	230	$119K
J1453	Injection, fosaprepitant, 1 mg	<1%	518	$113K
86003		<1%	1,464	$112K
87486		<1%	5,201	$110K
96409		<1%	1,218	$110K
72082		<1%	1,119	$110K
73552		<1%	2,804	$106K
86922		<1%	1,505	$106K
84439		<1%	10,967	$106K
96416		<1%	730	$105K
87581		<1%	5,188	$105K
72072		<1%	2,670	$103K
55175		<1%	407	$103K
84702		<1%	11,588	$100K
76937		<1%	1,530	$99K
88304		<1%	4,560	$99K
96402		<1%	1,552	$98K
73060		<1%	2,925	$97K
29581		<1%	2,443	$97K
J7040	Infusion, normal saline solution, sterile (500 ml = 1 unit)	<1%	49,710	$96K
95806		<1%	1,075	$95K
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	<1%	5,439	$94K
Q9950	Injection, sulfur hexafluoride lipid microspheres, per ml	<1%	2,856	$91K
77075		<1%	632	$91K
C8908	Magnetic resonance imaging without contrast followed by with contrast, breast; bilateral	<1%	188	$90K
64644		<1%	306	$89K
J9035	Injection, bevacizumab, 10 mg	<1%	25	$88K
86901		<1%	31,001	$88K
70480		<1%	308	$88K
83036	Hemoglobin; glycosylated (A1C)	<1%	10,466	$88K
J9355	Injection, trastuzumab, excludes biosimilar, 10 mg	<1%	32	$87K
93308		<1%	576	$86K
87040		<1%	15,977	$86K
92526		<1%	1,550	$86K
88360		<1%	581	$86K
77001		<1%	1,119	$85K
43762		<1%	634	$82K
12002		<1%	1,421	$82K
83540		<1%	11,143	$81K
49585		<1%	90	$79K
82784		<1%	5,513	$78K
73222		<1%	185	$78K
84112		<1%	1,940	$78K
73140		<1%	2,842	$77K
87522	Neg quan hep c or qual rna	<1%	2,219	$77K
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	<1%	3,890	$77K
70487		<1%	296	$77K
96368		<1%	4,028	$77K
82607		<1%	5,745	$76K
76942		<1%	857	$76K
73200		<1%	239	$74K
10005		<1%	207	$74K
71271		<1%	1,941	$74K
C1751	Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis)	<1%	1,067	$74K
51797		<1%	961	$73K
83605		<1%	10,123	$73K
94729		<1%	1,692	$73K
87070		<1%	19,251	$72K
86945		<1%	2,466	$70K
58563		<1%	27	$69K
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	21,944	$67K
42830		<1%	79	$67K
76000		<1%	757	$67K
76815	Ultrasound, pregnant uterus, real time with image documentation, limited	<1%	719	$67K
80074		<1%	2,070	$66K
97750		<1%	2,715	$65K
72050		<1%	1,448	$65K
J9070	Cyclophosphamide, 100 mg	<1%	300	$62K
71101		<1%	1,974	$62K
70470		<1%	165	$62K
Q5115	Injection, rituximab-abbs, biosimilar, (truxima), 10 mg	<1%	27	$61K
86140		<1%	17,813	$61K
29105		<1%	1,019	$61K
G1004	Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program	<1%	4,678	$61K
29125		<1%	1,622	$61K
85007		<1%	26,304	$60K
81003		<1%	45,356	$60K
Q5117	Injection, trastuzumab-anns, biosimilar, (kanjinti), 10 mg	<1%	22	$60K
58300		<1%	148	$60K
59820		<1%	57	$59K
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	18,400	$59K
C9463	Injection, aprepitant, 1 mg	<1%	253	$59K
J9173	Injection, durvalumab, 10 mg	<1%	57	$59K
J7060	5% dextrose/water (500 ml = 1 unit)	<1%	34,217	$59K
83021		<1%	4,340	$59K
94762		<1%	1,833	$59K
G0105	Colorectal cancer screening; colonoscopy on individual at high risk	<1%	128	$58K
C1889	Implantable/insertable device, not otherwise classified	<1%	31	$58K
29826		<1%	107	$58K
90715		<1%	4,455	$58K
29827		<1%	50	$57K
J3489	Injection, zoledronic acid, 1 mg	<1%	740	$57K
83516		<1%	2,118	$56K
82803		<1%	3,944	$56K
70250		<1%	941	$55K
J0690	Injection, cefazolin sodium, 500 mg	<1%	28,232	$55K
99214	Doctor's office visit, returning patient (more involved)	<1%	2,530	$54K
62270		<1%	322	$53K
64635		<1%	65	$53K
80069		<1%	8,431	$52K
76827		<1%	783	$52K
91200		<1%	770	$52K
J9045	Injection, carboplatin, 50 mg	<1%	2,206	$51K
92610		<1%	756	$51K
J2795	Injection, ropivacaine hydrochloride, 1 mg	<1%	9,526	$50K
72170		<1%	1,594	$50K
25605		<1%	161	$50K
97168		<1%	1,350	$50K
88313		<1%	982	$49K
82150		<1%	14,109	$48K
70360		<1%	1,571	$47K
J7120	Ringers lactate infusion, up to 1000 cc	<1%	31,446	$47K
87077		<1%	11,134	$47K
94660		<1%	791	$47K
36600		<1%	3,526	$47K
85379		<1%	10,258	$47K
J2930	Injection, methylprednisolone sodium succinate, up to 125 mg	<1%	9,569	$46K
Q0222	Injection, bebtelovimab, 175 mg	<1%	187	$46K
99155		<1%	1,976	$46K
Q9958	High osmolar contrast material, up to 149 mg/ml iodine concentration, per ml	<1%	3,255	$46K
36902		<1%	63	$45K
72081		<1%	595	$45K
87902		<1%	284	$45K
51741		<1%	764	$45K
97164		<1%	1,244	$45K
84100		<1%	11,565	$44K
J0330	Injection, succinylcholine chloride, up to 20 mg	<1%	12,158	$43K
94760		<1%	3,843	$43K
72020		<1%	819	$43K
96450		<1%	248	$43K
77076		<1%	603	$42K
64494		<1%	526	$42K
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	65,999	$42K
C1729	Catheter, drainage	<1%	1,504	$42K
97166		<1%	1,289	$42K
99153	Mod sedat endo service >5yrs	<1%	959	$41K
J3010	Injection, fentanyl citrate, 0.1 mg	<1%	55,552	$41K
54304		<1%	44	$41K
82330		<1%	3,749	$40K
J0561	Injection, penicillin g benzathine, 100,000 units	<1%	843	$40K
94664		<1%	8,625	$39K
78708		<1%	189	$39K
96523		<1%	1,823	$39K
77280		<1%	713	$39K
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	82,422	$38K
27130		<1%	15	$38K
94644		<1%	2,901	$38K
73000		<1%	1,180	$38K
86923		<1%	2,002	$38K
73080		<1%	1,264	$37K
87186		<1%	9,096	$36K
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	57,161	$36K
Q9966	Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml	<1%	4,105	$36K
J3370	Injection, vancomycin hcl, 500 mg	<1%	6,122	$36K
72070		<1%	889	$36K
82550		<1%	6,528	$36K
G0279	Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066)	<1%	1,988	$36K
88348		<1%	107	$35K
84145		<1%	2,396	$35K
72195		<1%	70	$35K
74270		<1%	241	$35K
J0780	Injection, prochlorperazine, up to 10 mg	<1%	9,448	$34K
64483		<1%	72	$34K
J0640	Injection, leucovorin calcium, per 50 mg	<1%	1,314	$33K
93976		<1%	398	$33K
J1170	Injection, hydromorphone, up to 4 mg	<1%	24,080	$33K
36591		<1%	1,578	$33K
J9267	Injection, paclitaxel, 1 mg	<1%	1,427	$33K
93926		<1%	359	$32K
86665		<1%	3,162	$31K
87205		<1%	14,420	$31K
73620		<1%	1,034	$31K
82378		<1%	1,686	$31K
82746		<1%	2,444	$31K
75565		<1%	97	$31K
83970		<1%	927	$30K
85652		<1%	13,223	$30K
J3301	Injection, triamcinolone acetonide, not otherwise specified, 10 mg	<1%	7,736	$30K
83615		<1%	4,697	$29K
J2250	Injection, midazolam hydrochloride, per 1 mg	<1%	57,348	$29K
99152		<1%	1,137	$29K
23350		<1%	252	$29K
93321		<1%	311	$29K
80197		<1%	1,967	$29K
G0381	Level 2 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment)	<1%	297	$28K
A9537	Technetium tc-99m mebrofenin, diagnostic, per study dose, up to 15 millicuries	<1%	985	$28K
97167		<1%	727	$28K
95874		<1%	383	$28K
14040		<1%	98	$28K
85576		<1%	766	$27K
85045		<1%	9,130	$27K
J0878	Injection, daptomycin, 1 mg	<1%	98	$27K
87400		<1%	8,325	$27K
77301		<1%	19	$27K
J1650	Injection, enoxaparin sodium, 10 mg	<1%	9,456	$27K
97165		<1%	656	$27K
J0171	Injection, adrenalin, epinephrine, 0.1 mg	<1%	4,919	$26K
76376		<1%	303	$26K
P9041	Infusion, albumin (human), 5%, 50 ml	<1%	1,149	$25K
22853		<1%	78	$25K
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	7,295	$25K
87634		<1%	804	$25K
86780		<1%	3,008	$25K
87210		<1%	14,038	$25K
88184		<1%	731	$25K
86664		<1%	2,332	$25K
76805	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation	<1%	287	$25K
A9585	Injection, gadobutrol, 0.1 ml	<1%	1,029	$25K
G0257	Unscheduled or emergency dialysis treatment for an esrd patient in a hospital outpatient department that is not certified as an esrd facility	<1%	128	$25K
24640		<1%	304	$24K
95911		<1%	126	$24K
82785		<1%	1,339	$24K
83883		<1%	2,018	$24K
70543		<1%	44	$24K
90375		<1%	17	$24K
73660		<1%	966	$24K
96401		<1%	355	$24K
77470		<1%	47	$23K
A9541	Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries	<1%	1,433	$23K
87804	Infectious agent antigen detection by immunoassay; Influenza, each type	<1%	7,478	$23K
Q9957	Injection, perflutren lipid microspheres, per ml	<1%	350	$22K
J9190	Injection, fluorouracil, 500 mg	<1%	3,009	$22K
C1758	Catheter, ureteral	<1%	1,726	$22K
74160		<1%	74	$22K
62328		<1%	69	$22K
J1642	Injection, heparin sodium, (heparin lock flush), per 10 units	<1%	12,929	$22K
82947		<1%	3,808	$22K
84132		<1%	6,151	$21K
72126		<1%	126	$21K
J2001	Injection, lidocaine hcl for intravenous infusion, 10 mg	<1%	26,347	$21K
58662		<1%	14	$21K
86334		<1%	1,280	$21K
86038		<1%	1,867	$20K
29515		<1%	522	$20K
43245		<1%	26	$20K
86870		<1%	404	$20K
70260		<1%	178	$20K
J2370	Injection, phenylephrine hcl, up to 1 ml	<1%	9,707	$19K
J2270	Injection, morphine sulfate, up to 10 mg	<1%	21,286	$19K
86304		<1%	1,142	$19K
11043		<1%	65	$19K
77012		<1%	105	$19K
88302		<1%	1,106	$18K
87075		<1%	2,274	$18K
90686		<1%	2,504	$18K
86328		<1%	434	$18K
92585		<1%	167	$17K
31624		<1%	26	$17K
88108		<1%	699	$17K
84403		<1%	752	$17K
88312		<1%	571	$17K
95885		<1%	244	$17K
J1626	Injection, granisetron hydrochloride, 100 mcg	<1%	3,084	$17K
A9562	Technetium tc-99m mertiatide, diagnostic, per study dose, up to 15 millicuries	<1%	304	$17K
94621		<1%	58	$17K
74022		<1%	436	$17K
73718		<1%	47	$16K
86803		<1%	1,724	$16K
85660		<1%	2,582	$16K
87340		<1%	2,521	$16K
J2805	Injection, sincalide, 5 micrograms	<1%	286	$16K
J0295	Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm	<1%	4,465	$16K
82533		<1%	1,081	$16K
J1200	Injection, diphenhydramine hcl, up to 50 mg	<1%	18,435	$16K
64636		<1%	48	$16K
86301		<1%	622	$16K
J0360	Injection, hydralazine hcl, up to 20 mg	<1%	3,378	$16K
43760		<1%	178	$16K
A9503	Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries	<1%	850	$16K
J2710	Injection, neostigmine methylsulfate, up to 0.5 mg	<1%	3,904	$16K
99156		<1%	974	$15K
J2543	Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams)	<1%	4,350	$15K
86663		<1%	2,203	$15K
86706		<1%	1,997	$15K
36590		<1%	53	$15K
43249		<1%	46	$15K
84238		<1%	540	$15K
G0008	Administration of influenza virus vaccine	<1%	308	$14K
C9113	Injection, pantoprazole sodium, per vial	<1%	7,442	$14K
85240		<1%	966	$14K
87046		<1%	2,405	$14K
81002		<1%	2,645	$14K
94645		<1%	687	$14K
Q9965	Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml	<1%	1,155	$13K
J0500	Injection, dicyclomine hcl, up to 20 mg	<1%	701	$13K
90688		<1%	2,537	$13K
82105		<1%	864	$13K
53020		<1%	12	$13K
80164		<1%	1,263	$13K
38222		<1%	45	$13K
J1040	Injection, methylprednisolone acetate, 80 mg	<1%	3,257	$13K
72083		<1%	117	$13K
87529		<1%	628	$13K
73564		<1%	411	$13K
36416		<1%	3,769	$12K
86704		<1%	1,036	$12K
84165		<1%	1,438	$12K
83520		<1%	933	$12K
86147		<1%	355	$12K
85384		<1%	1,635	$12K
84481		<1%	873	$12K
87799		<1%	387	$12K
83921		<1%	662	$11K
64718		<1%	13	$11K
J7298	Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg	<1%	15	$11K
20610		<1%	88	$11K
83655		<1%	943	$11K
85014		<1%	5,766	$11K
78582		<1%	71	$11K
84156		<1%	2,554	$11K
J0248	Injection, remdesivir, 1 mg	<1%	76	$11K
90460	Immunization administration through 18 years of age via any route, first or only component	<1%	3,239	$11K
82570		<1%	2,548	$11K
J9263	Injection, oxaliplatin, 0.5 mg	<1%	363	$10K
84460		<1%	2,150	$10K
83001		<1%	694	$10K
80076		<1%	1,360	$10K
86800		<1%	711	$10K
C2628	Catheter, occlusion	<1%	98	$10K
87088		<1%	2,920	$10K
84146		<1%	623	$10K
82248		<1%	2,327	$10K
76506		<1%	72	$10K
J9370	Vincristine sulfate, 1 mg	<1%	1,689	$10K
95909		<1%	112	$10K
84550		<1%	2,557	$10K
86008		<1%	127	$10K
J1610	Injection, glucagon hydrochloride, per 1 mg	<1%	122	$10K
84153		<1%	406	$10K
82247		<1%	2,174	$10K
82140		<1%	762	$9K
J2274	Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg	<1%	10,454	$9K
92523		<1%	100	$9K
77399		<1%	114	$9K
76857		<1%	99	$9K
88182		<1%	204	$9K
P9035	Platelets, pheresis, leukocytes reduced, each unit	<1%	22	$9K
73720		<1%	16	$9K
88173		<1%	339	$9K
93312		<1%	28	$9K
87045		<1%	1,643	$9K
22845		<1%	44	$9K
87427		<1%	1,468	$9K
84295		<1%	2,831	$9K
M0222	Intravenous injection, bebtelovimab, includes injection and post administration monitoring	<1%	93	$9K
J7042	5% dextrose/normal saline (500 ml = 1 unit)	<1%	5,802	$9K
J3475	Injection, magnesium sulfate, per 500 mg	<1%	7,110	$9K
85597		<1%	599	$8K
12013		<1%	149	$8K
29505		<1%	140	$8K
85018		<1%	4,580	$8K
74328		<1%	71	$8K
75561		<1%	18	$8K
89051		<1%	1,793	$8K
93923		<1%	68	$8K
72220		<1%	225	$7K
J3480	Injection, potassium chloride, per 2 meq	<1%	4,516	$7K
G0383	Level 4 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment)	<1%	36	$7K
82668		<1%	298	$7K
87081		<1%	1,174	$7K
77338		<1%	33	$7K
J1644	Injection, heparin sodium, per 1000 units	<1%	5,770	$7K
88377		<1%	53	$7K
83525		<1%	518	$7K
86146		<1%	299	$7K
76816	Ultrasound, pregnant uterus, real time with image documentation, follow-up	<1%	131	$7K
82270		<1%	2,467	$6K
81243		<1%	141	$6K
G0283	Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care	<1%	325	$6K
70490		<1%	30	$6K
J2310	Injection, naloxone hydrochloride, per 1 mg	<1%	967	$6K
82977		<1%	1,030	$6K
84305		<1%	328	$6K
96377		<1%	134	$6K
86769		<1%	332	$6K
10022		<1%	45	$6K
86480		<1%	124	$6K
82945		<1%	1,201	$6K
J1953	Injection, levetiracetam, 10 mg	<1%	2,223	$6K
84157		<1%	1,267	$6K
36569		<1%	14	$6K
84436		<1%	971	$6K
54360		<1%	34	$6K
86308		<1%	2,432	$6K
97014		<1%	386	$5K
90675		<1%	20	$5K
85397		<1%	209	$5K
73723		<1%	18	$5K
95711		<1%	82	$5K
27096		<1%	18	$5K
83010		<1%	537	$5K
90732		<1%	253	$5K
87483		<1%	39	$5K
J9201	Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg	<1%	203	$5K
86481		<1%	58	$5K
85347		<1%	950	$5K
83002		<1%	320	$5K
82435		<1%	1,889	$5K
84480		<1%	472	$5K
J9206	Injection, irinotecan, 20 mg	<1%	275	$5K
72192		<1%	15	$5K
82010		<1%	1,197	$5K
77049		<1%	15	$5K
52000		<1%	14	$5K
J2920	Injection, methylprednisolone sodium succinate, up to 40 mg	<1%	1,871	$4K
Q3014	Telehealth originating site facility fee	<1%	336	$4K
99215	Doctor's office visit, returning patient (complex)	<1%	205	$4K
J3420	Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg	<1%	1,797	$4K
70481		<1%	31	$4K
86703		<1%	711	$4K
95912		<1%	13	$4K
J1956	Injection, levofloxacin, 250 mg	<1%	1,685	$4K
J3411	Injection, thiamine hcl, 100 mg	<1%	2,453	$4K
73100		<1%	174	$4K
85246		<1%	201	$4K
J2765	Injection, metoclopramide hcl, up to 10 mg	<1%	6,082	$4K
92587		<1%	77	$4K
85613		<1%	492	$4K
85612		<1%	291	$4K
95908		<1%	52	$4K
86708		<1%	367	$4K
85245		<1%	201	$3K
86431		<1%	684	$3K
94618		<1%	147	$3K
49452		<1%	13	$3K
80177		<1%	298	$3K
J2060	Injection, lorazepam, 2 mg	<1%	5,891	$3K
C1730	Catheter, electrophysiology, diagnostic, other than 3d mapping (19 or fewer electrodes)	<1%	15	$3K
87102		<1%	417	$3K
J0456	Injection, azithromycin, 500 mg	<1%	1,420	$3K
86160		<1%	223	$3K
J0461	Injection, atropine sulfate, 0.01 mg	<1%	1,030	$3K
J0694	Injection, cefoxitin sodium, 1 gm	<1%	769	$3K
82310		<1%	517	$3K
83003		<1%	50	$3K
84450		<1%	406	$3K
85244		<1%	182	$3K
82670		<1%	132	$3K
77003		<1%	45	$3K
69209		<1%	51	$3K
75625		<1%	15	$3K
88112		<1%	137	$3K
87420		<1%	863	$3K
90632		<1%	156	$2K
J9000	Injection, doxorubicin hydrochloride, 10 mg	<1%	133	$2K
86376		<1%	235	$2K
75710		<1%	14	$2K
M0239	Intravenous infusion, bamlanivimab-xxxx, includes infusion and post administration monitoring	<1%	24	$2K
J1940	Injection, furosemide, up to 20 mg	<1%	2,791	$2K
J2790	Injection, rho d immune globulin, human, full dose, 300 micrograms (1500 i.u.)	<1%	40	$2K
J2916	Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg	<1%	75	$2K
69200		<1%	42	$2K
88300		<1%	228	$2K
87149		<1%	71	$2K
86617		<1%	128	$2K
J0881	Injection, darbepoetin alfa, 1 microgram (non-esrd use)	<1%	23	$2K
A9540	Technetium tc-99m macroaggregated albumin, diagnostic, per study dose, up to 10 millicuries	<1%	71	$2K
87177		<1%	337	$2K
86757		<1%	137	$2K
81479	Unlisted molecular pathology procedure	<1%	82	$2K
92567		<1%	122	$2K
82747		<1%	119	$2K
J9171	Injection, docetaxel, 1 mg	<1%	16	$2K
73600		<1%	69	$2K
88311		<1%	263	$2K
87015		<1%	470	$2K
82397		<1%	129	$2K
A9270	Non-covered item or service	<1%	30,293	$2K
74420		<1%	31	$2K
77417		<1%	34	$2K
84520		<1%	1,195	$2K
83930		<1%	432	$2K
83521		<1%	60	$2K
84134		<1%	166	$2K
95873		<1%	70	$2K
82043		<1%	305	$2K
82731		<1%	101	$2K
J9060	Injection, cisplatin, powder or solution, 10 mg	<1%	104	$2K
86356		<1%	17	$2K
97035		<1%	133	$1K
86360		<1%	36	$1K
87324		<1%	301	$1K
82805		<1%	37	$1K
76604		<1%	13	$1K
J8540	Dexamethasone, oral, 0.25 mg	<1%	2,429	$1K
76811	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed	<1%	33	$1K
82379		<1%	89	$1K
86880		<1%	253	$1K
82525		<1%	81	$1K
86618		<1%	138	$1K
J2550	Injection, promethazine hcl, up to 50 mg	<1%	2,438	$1K
87535		<1%	29	$1K
J9260	Injection, methotrexate sodium, 50 mg	<1%	345	$1K
J0290	Injection, ampicillin sodium, 500 mg	<1%	390	$1K
84432		<1%	107	$1K
90461		<1%	145	$1K
87116		<1%	190	$1K
94200		<1%	325	$1K
84270		<1%	70	$1K
16020		<1%	29	$985.72
30300		<1%	39	$968.26
82810		<1%	77	$954.92
83986		<1%	632	$946.65
80202		<1%	96	$926.36
74241		<1%	16	$916.46
94667		<1%	61	$884.86
69210		<1%	12	$807.89
87206		<1%	203	$740.10
J1020	Injection, methylprednisolone acetate, 20 mg	<1%	311	$729.84
86592		<1%	217	$727.44
80175		<1%	66	$701.07
81241		<1%	13	$692.80
72202		<1%	12	$638.60
83498		<1%	34	$633.08
84681		<1%	18	$619.53
82657		<1%	28	$618.62
82542		<1%	29	$618.39
J1720	Injection, hydrocortisone sodium succinate, up to 100 mg	<1%	75	$593.93
J2175	Injection, meperidine hydrochloride, per 100 mg	<1%	948	$592.44
84479		<1%	89	$555.66
85303		<1%	52	$544.18
85306		<1%	44	$542.12
0031A		<1%	16	$501.60
64495		<1%	12	$496.47
99151		<1%	30	$489.64
99195		<1%	21	$488.00
82365		<1%	57	$474.89
J1580	Injection, garamycin, gentamicin, up to 80 mg	<1%	341	$454.31
86644		<1%	18	$453.06
73020		<1%	14	$419.52
J0692	Injection, cefepime hydrochloride, 500 mg	<1%	174	$410.87
J1790	Injection, droperidol, up to 5 mg	<1%	321	$391.03
86762		<1%	86	$390.86
82652		<1%	13	$380.24
83020		<1%	29	$370.64
85300		<1%	45	$356.68
70160		<1%	12	$338.10
86359		<1%	16	$336.40
86355		<1%	16	$336.40
J1630	Injection, haloperidol, up to 5 mg	<1%	514	$294.45
84402		<1%	17	$286.52
84207		<1%	12	$285.78
82232		<1%	30	$275.06
82627		<1%	20	$273.42
82139		<1%	17	$265.86
88175	Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer	<1%	19	$263.41
82950		<1%	30	$246.95
J3360	Injection, diazepam, up to 5 mg	<1%	17	$225.08
84075		<1%	34	$216.05
J1250	Injection, dobutamine hydrochloride, per 250 mg	<1%	75	$215.00
86021		<1%	17	$208.45
0279U		<1%	29	$207.54
85250		<1%	14	$206.58
71010		<1%	16	$195.64
84155		<1%	16	$188.86
J2210	Injection, methylergonovine maleate, up to 0.2 mg	<1%	12	$174.09
86225		<1%	21	$167.49
80183		<1%	14	$153.22
86300		<1%	12	$142.55
85670		<1%	33	$133.00
80178		<1%	33	$121.03
87425		<1%	16	$119.80
J0744	Injection, ciprofloxacin for intravenous infusion, 200 mg	<1%	146	$116.81
86705		<1%	26	$112.34
84300		<1%	39	$111.32
J2800	Injection, methocarbamol, up to 10 ml	<1%	29	$92.54
84630		<1%	13	$91.12
J9250	Methotrexate sodium, 5 mg	<1%	32	$90.93
J7644	Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram	<1%	110	$80.57
J7611	Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg	<1%	331	$71.64
J0702	Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg	<1%	20	$69.51
G8978	Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals	<1%	1,113	$58.67
90685		<1%	17	$54.64
84133		<1%	13	$28.38
J0280	Injection, aminophyllin, up to 250 mg	<1%	13	$20.58
G8984	Carrying, moving & handling objects functional limitation, current status, at therapy episode outset and at reporting intervals	<1%	269	$15.81
G8996	Swallowing functional limitation, current status at therapy episode outset and at reporting intervals	<1%	109	$12.00
J3105	Injection, terbutaline sulfate, up to 1 mg	<1%	28	$9.32
C8937	Computer-aided detection, including computer algorithm analysis of breast mri image data for lesion detection/characterization, pharmacokinetic analysis, with further physician review for interpretation (list separately in addition to code for primary procedure)	<1%	16	$1.17
G8985	Carrying, moving and handling objects, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	<1%	308	$1.00
Q0244	Injection, casirivimab and imdevimab, 1200 mg	<1%	16	$0.13
Q0243	Injection, casirivimab and imdevimab, 2400 mg	<1%	16	$0.01
G8979	Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	0%	1,017	$0.00
G8997	Swallowing functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	0%	114	$0.00
G8981	Changing & maintaining body position functional limitation, current status, at therapy episode outset and at reporting intervals	0%	188	$0.00
G8980	Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting	0%	354	$0.00
G8987	Self care functional limitation, current status, at therapy episode outset and at reporting intervals	0%	68	$0.00
G8982	Changing & maintaining body position functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	0%	205	$0.00
G8998	Swallowing functional limitation, discharge status, at discharge from therapy or to end reporting	0%	53	$0.00
G8988	Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	0%	55	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialGAST, SHELLEY (VP MANAGED CARE)

Same official

Other billing entities under GAST, SHELLEY

Full network →

Provider	Location	Paid
Norton Hospitals, INC	Louisville, KY	$299.00M
Community Medical Associates, INC.	Louisville, KY	$135.33M
Norton Childrens Medical Group, LLC	Louisville, KY	$107.36M
Community Medical Associates, INC.	Louisville, KY	$48.97M
Norton Clark Hospital, LLC	Jeffersonville, IN	$19.62M
Norton - Kings Daughters Health INC	Madison, IN	$11.81M
Norton Scott Hospital, LLC	Scottsburg, IN	$9.17M
Norton Clark Physician Practices, LLC	Clarksville, IN	$7.07M
Norton Hospitals INC	Louisville, KY	$3.38M
Community Medical Associates, INC.	Louisville, KY	$1.21M
Norton Children's Medical Group, LLC	Louisville, KY	$1.15M
Community Medical Associates, INC.	Louisville, KY	$957K
Community Medical Associates, INC.	Louisville, KY	$808K
Norton Scott Hospital, LLC	Scottsburg, IN	$560K
Norton Hospitals, INC	Louisville, KY	$438K
Community Medical Associates, INC.	Louisville, KY	$357K
Norton Clark Physician Practices, LLC	Sellersburg, IN	$273K
Norton Children's Medical Group, LLC	Louisville, KY	$260K
Norton Children's Medical Group, LLC	Louisville, KY	$238K
Norton Children's Medical Group, LLC	Louisville, KY	$189K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.